Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment

Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment

The incidence of the micro- and macrovascular complications of diabetes is rising, mirroring the increase in the worldwide prevalence. Arguably, the most common microvascular complication is neuropathy, leading to deleterious changes in both the structure and function of neurons. Amongst the various...

Full description

Bibliographic Details
Main Authors:	Theresa Meldgaard, Søren Schou Olesen, Adam D. Farmer, Klaus Krogh, Anne Astrid Wendel, Birgitte Brock, Asbjørn Mohr Drewes, Christina Brock
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2018/3827301

Similar Items

Pathophysiology and management of diabetic gastroenteropathy
by: Theresa Meldgaard, et al.
Published: (2019-06-01)

The Pain System in Oesophageal Disorders: Mechanisms, Clinical Characteristics, and Treatment
by: Christian Lottrup, et al.
Published: (2011-01-01)

Study protocol for a multicentre, randomised, parallel group, sham-controlled clinical trial investigating the effect of transcutaneous vagal nerve stimulation on gastrointestinal symptoms in people with diabetes complicated with diabetic autonomic neuropathy: the DAN-VNS Study
by: Christina Brock, et al.
Published: (2021-01-01)

Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham controlled clinical trial.
by: Janusiya Anajan Muthulingam, et al.
Published: (2021-01-01)

Evolving paradigms in the treatment of opioid-induced bowel dysfunction
by: Jakob Lykke Poulsen, et al.
Published: (2015-11-01)

Cingulate glutamate levels associate with pain in chronic pancreatitis patients
by: Tine Maria Hansen, et al.
Published: (2019-01-01)

Immunopathogenic mechanisms of enteropathy in Africans
by: Veitch, Andrew McCulloch
Published: (2000)

The mechanism of Wumei Wan on treating diabetes enteropathy based on the network pharmacology
by: Zong-Ying Xu, et al.
Published: (2021-04-01)

NSAID enteropathy
by: E. N. Kareva
Published: (2020-02-01)

Studies into the pathogenic mechanism of NSAID-enteropathy
by: Sigthorsson, Gudmundur
Published: (2002)

Characterization of monogenic enteropathies
by: Charbit-Henrion, Fabienne
Published: (2016)

Enteropathy Associated with Olmesartan
by: Bruno Moreira da Silva, et al.
Published: (2016-03-01)

Protein-losing enteropathy
by: A I Parfenov, et al.
Published: (2017-02-01)

The aetiology of the proliferative enteropathies
by: McOrist, S.
Published: (1988)

Sprue-Like Enteropathy Associated With Olmesartan: A New Kid on the Enteropathy Block
by: Isabel A. Hujoel, et al.
Published: (2016-03-01)

Sprue-Like Enteropathy Associated with Olmesartan: An Unrecognized Emerging Drug-Induced Enteropathy?
by: Luís Carvalho Lourenço, et al.
Published: (2016-11-01)

Effect of early enteral nutrition on intestinal permeability, protein-losing enteropathy and outcome in canine parvoviral enteritis
by: Mohr, Albertus Jacobus
Published: (2013)

Prediction of opioid dose in cancer pain patients using genetic profiling: not yet an option with support vector machine learning
by: Anne Estrup Olesen, et al.
Published: (2018-01-01)

Congenital Tufting Enteropathy: Biology, Pathogenesis and Mechanisms
by: Barun Das, et al.
Published: (2021-12-01)

Assessment of Gastrointestinal Autonomic Dysfunction: Present and Future Perspectives
by: Ditte S. Kornum, et al.
Published: (2021-03-01)

NSAID Enteropathy: A Review of the Disease Entity and Its Distinction from Crohn’s Enteropathy
by: Smita Esther Raju, et al.
Published: (2019-07-01)

Clinical potential of naloxegol in the management of opioid-induced bowel dysfunction
by: Poulsen JL, et al.
Published: (2014-09-01)

Sensitivity of quantitative sensory models to morphine analgesia in humans
by: Olesen AE, et al.
Published: (2014-12-01)

The treating dogs for enteropathy with PLE
by: Ye. Mostovyi, et al.
Published: (2020-08-01)

Enteropathy associated T-cell lymphoma
by: Bakrač Milena, et al.
Published: (2007-01-01)

Changes in the liver in glutenic enteropathy
by: E A Sabelnikova, et al.
Published: (2003-02-01)

Chagasic enteropathy Enteropatia chagásica
by: Ulysses G. Meneghelli
Published: (2004-06-01)

Modeling undernutrition with enteropathy in mice
by: Emmeline Salameh, et al.
Published: (2020-09-01)

Genetische Aberrationen von Enteropathie-Typ T-Zell-Lymphomen
by: Baumgärtner, Anne Katrin
Published: (2004)

Thyroid Autoimmunity and Gluten-Sensitive Enteropathy in Children with Type 1 Diabetes Mellitus
by: Gafur Doğdu, et al.
Published: (2012-06-01)

Acute physiological and electrical accentuation of vagal tone has no effect on pain or gastrointestinal motility in chronic pancreatitis
by: Juel J, et al.
Published: (2017-05-01)

Towards a neurobiological understanding of pain in chronic pancreatitis: mechanisms and implications for treatment
by: Søren S. Olesen, et al.
Published: (2017-12-01)

Model for Electrical Field Distribution in the Human Esophagus during Stimulation with Patch and Ring Electrodes
by: Christina Brock, et al.
Published: (2011-01-01)

Protein-Losing Enteropathy in Primary Lymphangiectasia
by: Bernard Crutzen, et al.
Published: (2020-06-01)

Olmesartan-Induced Sprue Like Enteropathy
by: Liliana Carneiro, et al.
Published: (2016-03-01)

Strongyloides hyperinfection presenting as proteinlosing enteropathy
by: Ilavarasi Lakshmanan, et al.
Published: (2017-01-01)

Current approaches to the diagnosis and treatment for enteropathies
by: A I Parfenov
Published: (2014-02-01)

Severe spruelike enteropathy due to olmesartan
by: Gioia Fiorucci, et al.
Published: (2014-02-01)

Clinical updates on diagnosing glutensensitive enteropathy
by: Faruk Hadziselimovic, et al.
Published: (2011-11-01)

Protein-Losing Enteropathy in Ulcerative Colitis
by: Ryan Ungaro, et al.
Published: (2012-04-01)